Currently holds a position at Catalyst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Operating Officer, Chief Scientific Officer | Catalyst Pharmaceuticals Inc | Jan. 21, 2011 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-11-23 | 2022-11-23 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
20,000
-3.5%
17.34346,740 USD |
20,000 -3.5% | 17.34 | 346,740 USD | |
2022-11-23 | 2022-11-21 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
80,000
-12.2%
15.281,222,080 USD |
80,000 -12.2% | 15.28 | 1,222,080 USD | |
2022-09-15 | 2022-09-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
75,000
-10.3%
16.851,263,450 USD |
75,000 -10.3% | 16.85 | 1,263,450 USD | |
2022-09-15 | 2022-09-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
7,933
-1.1%
17.11135,742 USD |
7,933 -1.1% | 17.11 | 135,742 USD | |
2022-09-15 | 2022-09-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
25,000
-3.3%
17.01425,175 USD |
25,000 -3.3% | 17.01 | 425,175 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
31,425
-4.0%
13.43422,163 USD |
31,425 -4.0% | 13.43 | 422,163 USD | |
2022-08-19 | 2022-08-18 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
118,575
-13.5%
13.561,607,758 USD |
118,575 -13.5% | 13.56 | 1,607,758 USD | |
2021-08-26 | 2021-08-25 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
80,000
-9.7%
5.56444,640 USD |
80,000 -9.7% | 5.56 | 444,640 USD | |
2021-08-17 | 2021-08-13 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
40,963
-5.5%
6.09249,416 USD |
40,963 -5.5% | 6.09 | 249,416 USD |